Workflow
私募6月调研逾1700次,迈威生物成最受关注公司

Group 1 - In June, a total of 751 private equity managers participated in A-share listed company research, covering 387 stocks across 28 Shenwan primary industries, with a total of 1,769 research instances [1] - The most researched stock in June was Maiwei Biotechnology, which received 51 research instances, attracting attention from major private equity firms [1] - The electronics and computer industries each had two stocks in the top ten most researched, with Haiguang Information and Zhongke Shuguang both receiving 39 research instances, ranking second [1][2] Group 2 - The electronics industry was the most favored by private equity research, with 56 stocks receiving a total of 275 research instances [2][3] - The pharmaceutical and biological industry followed closely, with 41 stocks receiving a total of 266 research instances [3] - The mechanical equipment industry had 52 stocks that were researched a total of 234 times, while the computer industry had 36 stocks with 213 research instances [3] Group 3 - A total of 85 private equity institutions actively participated in A-share research, with Zhengyuan Investment being the most active, conducting 35 research instances [3] - Among the top ten private equity firms, two were billion-dollar firms, with Panjing Investment and Juming Investment conducting 19 and 13 research instances, respectively [3] - In June, 31 billion-dollar private equity firms participated in A-share research, totaling 176 research instances, with several firms conducting at least ten research instances [3]